Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

A comparison of two questionnaires on Informed Consent for extended criteria liver donors.

Bruzzone P, Giannarelli D.

Ann Ital Chir. 2015 May 14;86. pii: S0003469X15023775. [Epub ahead of print]

PMID:
25985101
2.

Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.

Radio FC, Majore S, Aurizi C, Sorge F, Biolcati G, Bernabini S, Giotti I, Torricelli F, Giannarelli D, De Bernardo C, Grammatico P.

Blood Cells Mol Dis. 2015 Jun;55(1):71-5. doi: 10.1016/j.bcmd.2015.04.001. Epub 2015 Apr 16.

PMID:
25976471
3.

Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review.

Panici PB, Tomao F, Domenici L, Giannini A, Giannarelli D, Palaia I, Di Donato V, Musella A, Angioli R, Muzii L.

Gynecol Oncol. 2015 Apr 15. pii: S0090-8258(15)00726-X. doi: 10.1016/j.ygyno.2015.03.013. [Epub ahead of print]

PMID:
25887098
4.

Association between anemia and multiple sclerosis.

Koudriavtseva T, Renna R, Plantone D, Mandoj C, Piattella MC, Giannarelli D.

Eur Neurol. 2015;73(3-4):233-7. doi: 10.1159/000381212. Epub 2015 Mar 21.

PMID:
25823947
5.

Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.

Molica S, Giannarelli D, Mirabelli R, Levato L, Russo A, Linardi M, Gentile M, Morabito F.

Eur J Haematol. 2015 Mar 27. doi: 10.1111/ejh.12550. [Epub ahead of print]

PMID:
25819739
6.

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.

Calabrò L, Morra A, Fonsatti E, Cutaia O, Fazio C, Annesi D, Lenoci M, Amato G, Danielli R, Altomonte M, Giannarelli D, Di Giacomo AM, Maio M.

Lancet Respir Med. 2015 Apr;3(4):301-9. doi: 10.1016/S2213-2600(15)00092-2. Epub 2015 Mar 26.

PMID:
25819643
7.

Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: sensitivity analysis of randomized trials.

Carbognin L, Sperduti I, Nortilli R, Brunelli M, Vicentini C, Pellini F, Pollini GP, Giannarelli D, Tortora G, Bria E.

Cancer Treat Rev. 2015 Mar;41(3):262-70. doi: 10.1016/j.ctrv.2015.02.003. Epub 2015 Feb 9. Review.

PMID:
25683304
8.

Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.

Fabi A, Moscetti L, Ciccarese M, Caramanti M, Salesi N, La Verde N, Russillo M, Generali D, Scandurra G, Vari S, Pacetti U, Cognetti F, Giannarelli D.

Future Oncol. 2015;11(3):431-8. doi: 10.2217/fon.14.271.

PMID:
25675124
9.

A randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E.

J Gastrointest Surg. 2015 Apr;19(4):722-9. doi: 10.1007/s11605-015-2743-1. Epub 2015 Jan 17.

PMID:
25595308
10.

Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.

Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M.

World J Urol. 2014 Dec 27. [Epub ahead of print]

PMID:
25542395
11.

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.

Di Giacomo AM, Ascierto PA, Queirolo P, Pilla L, Ridolfi R, Santinami M, Testori A, Simeone E, Guidoboni M, Maurichi A, Orgiano L, Spadola G, Del Vecchio M, Danielli R, Calabrò L, Annesi D, Giannarelli D, Maccalli C, Fonsatti E, Parmiani G, Maio M.

Ann Oncol. 2015 Apr;26(4):798-803. doi: 10.1093/annonc/mdu577. Epub 2014 Dec 23.

PMID:
25538176
12.

Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.

Molica S, Giannarelli D, Levato L, Gentile M, Mirabelli R, Morabito F.

Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):e55-60. doi: 10.1016/j.clml.2014.09.003. Epub 2014 Sep 28.

PMID:
25445470
13.

Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study.

Giorlandino C, Cignini P, Padula F, Giannarelli D, d'Emidio L, Aloisi A, Plotti F, Angioli R.

Am J Obstet Gynecol. 2015 Mar;212(3):335.e1-7. doi: 10.1016/j.ajog.2014.10.003. Epub 2014 Oct 8.

PMID:
25305408
14.

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.

Vici P, Pizzuti L, Natoli C, Moscetti L, Mentuccia L, Vaccaro A, Sergi D, Di Lauro L, Trenta P, Seminara P, Santini D, Iezzi L, Tinari N, Bertolini I, Sini V, Mottolese M, Giannarelli D, Giotta F, Maugeri-Saccà M, Barba M, Marchetti P, Michelotti A, Sperduti I, Gamucci T.

Breast Cancer Res Treat. 2014 Oct;147(3):599-607. doi: 10.1007/s10549-014-3133-1. Epub 2014 Sep 19.

15.

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis.

Bria E, Massari F, Maines F, Pilotto S, Bonomi M, Porta C, Bracarda S, Heng D, Santini D, Sperduti I, Giannarelli D, Cognetti F, Tortora G, Milella M.

Crit Rev Oncol Hematol. 2015 Jan;93(1):50-9. doi: 10.1016/j.critrevonc.2014.08.001. Epub 2014 Aug 18.

PMID:
25195095
16.

Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.

Molica S, Giannarelli D, Mirabelli R, Levato L, Gentile M, Lentini M, Morabito F.

Expert Rev Hematol. 2014 Oct;7(5):691-5. doi: 10.1586/17474086.2014.954542. Epub 2014 Aug 31.

PMID:
25174547
17.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2014 May 14;3:e28780. eCollection 2014.

18.

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).

Molica S, Giannarelli D, Levato L, Mirabelli R, Gentile M, Lentini M, Morabito F.

Int J Hematol. 2014 Sep;100(3):290-5. doi: 10.1007/s12185-014-1634-7. Epub 2014 Jul 27.

PMID:
25064370
19.

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.

Gentile M, Mauro FR, Rossi D, Vincelli I, Tripepi G, Recchia AG, De Stefano L, Campanelli M, Giannarelli D, Bossio S, Morabito L, Vigna E, Gaidano G, Foà R, Morabito F.

Br J Haematol. 2014 Oct;167(2):224-32. doi: 10.1111/bjh.13032. Epub 2014 Jul 11.

PMID:
25041609
20.

Features and organization of Pain Centers in the Lazio Region, Italy, in 2011.

Latina R, De Marinis MG, Baglìo G, Cattaruzza MS, Notaro P, Guzzetti V, Osborn J, Sansoni J, Giannarelli D, Piredda M, D'Angelo D, Mastroianni C, Casale G, Gatti A, Tarsitani G, Pain Centers Group PC.

Ann Ig. 2014 Jul-Aug;26(4):367-79. doi: 10.7416/ai.2014.1996.

PMID:
25001126
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk